Paper37768367
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.
Jesus MM and 20 others. Parasitol Res, 2023. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis. Papers, record 37768367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37768367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leishmaniasis | Major topic |
| Leishmaniasis, Visceral | Major topic |
| Leishmania infantum | Major topic |
| Saponins | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Micelles | |
| Leukocytes, Mononuclear | |
| Recombinant Proteins | |
| Adjuvants, Immunologic | |
| Cytokines | |
| Vaccination | |
| Mice, Inbred BALB C | |
| Antigens, Protozoan |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12819086 | Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. | Infect Immun | 2003 | https://conductscience.org/library/papers/12819086 | PubMed |
| 2 | 31155395 | Diagnostic evaluation of the amastin protein from Leishmania infantum in canine and human visceral leishmaniasis and immunogenicity in human cells derived from patients and healthy controls. | Diagn Microbiol Infect Dis | 2019 | https://conductscience.org/library/papers/31155395 | PubMed |
| 3 | 32949849 | Leishmania infantum transfected with toxic plasmid induces protection in mice infected with wild type L. infantum or L. amazonensis. | Mol Immunol | 2020 | https://conductscience.org/library/papers/32949849 | PubMed |
| 4 | 8358705 | Leishmaniases of the New World: current concepts and implications for future research. | Clin Microbiol Rev | 1993 | https://conductscience.org/library/papers/8358705 | PubMed |
| 5 | 32485231 | Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasis. | Microb Pathog | 2020 | https://conductscience.org/library/papers/32485231 | PubMed |
| 6 | 29240765 | Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. | PLoS Negl Trop Dis | 2017 | https://conductscience.org/library/papers/29240765 | PubMed |
| 7 | 29922885 | Molecular Diagnosis of Visceral Leishmaniasis. | Mol Diagn Ther | 2018 | https://conductscience.org/library/papers/29922885 | PubMed |
| 8 | 36986434 | Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/36986434 | PubMed |
| 9 | 32656269 | Review on the Role of Host Immune Response in Protection and Immunopathogenesis during Cutaneous Leishmaniasis Infection. | J Immunol Res | 2020 | https://conductscience.org/library/papers/32656269 | PubMed |
| 10 | 18295939 | Vaccines for leishmaniasis in the fore coming 25 years. | Vaccine | 2008 | https://conductscience.org/library/papers/18295939 | PubMed |
| 11 | 34511000 | From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection. | Expert Rev Vaccines | 2021 | https://conductscience.org/library/papers/34511000 | PubMed |
| 12 | 32972825 | A historical review of the role of cytokines involved in leishmaniasis. | Cytokine | 2021 | https://conductscience.org/library/papers/32972825 | PubMed |
| 13 | 22272364 | Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach. | PLoS Negl Trop Dis | 2012 | https://conductscience.org/library/papers/22272364 | PubMed |
| 14 | 26872697 | Interleukin-35 Limits Anti-Tumor Immunity. | Immunity | 2016 | https://conductscience.org/library/papers/26872697 | PubMed |
| 15 | 33825036 | Leishmaniasis: where are we and where are we heading? | Parasitol Res | 2021 | https://conductscience.org/library/papers/33825036 | PubMed |
| 16 | 35437797 | Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasis. | Parasite Immunol | 2022 | https://conductscience.org/library/papers/35437797 | PubMed |
| 17 | 32526867 | Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/32526867 | PubMed |
| 18 | 16305646 | Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome. | Scand J Immunol | 2005 | https://conductscience.org/library/papers/16305646 | PubMed |
| 19 | 2063957 | Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. | Am J Trop Med Hyg | 1991 | https://conductscience.org/library/papers/2063957 | PubMed |
| 20 | 25476593 | IL-35: a potential therapeutic target for controlling hepatitis B virus infection. | J Dig Dis | 2015 | https://conductscience.org/library/papers/25476593 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40900277 | Leishmania pyruvate kinase and mitochondrial processing protease: Two novel vaccine candidates, selected via a seroproteomic approach, trigger a protective immune response against murine cutaneous leishmaniasis. | Med Microbiol Immunol | 2025 | https://conductscience.org/library/papers/40900277 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37768367
GET https://conductscience.org/api/papers/v1/37768367/authors?page=2